PHARMACYTE BIOTECH, INC. Total Liabilities
PHARMACYTE BIOTECH, INC. (PMCB) had Total Liabilities of $6.90 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-09-14
- 2026-07-31: Liabilities $6.90M.
- 2026-04-30: Liabilities $11.77M.
- 2026-01-31: Liabilities $16.47M.
- 2025-10-31: Liabilities $19.42M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-07-31 | $6.90M 10-Q · filed 2026-09-14 | |
| 2026-04-30 | $11.77M 10-Q · filed 2026-09-14 | |
| 2026-01-31 | $16.47M 10-Q · filed 2026-03-17 | |
| 2025-10-31 | $19.42M 10-Q · filed 2025-12-18 | |
| 2025-07-31 | $1.52M 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $3.28M 10-K · filed 2026-07-29 | |
| 2025-01-31 | $3.58M 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $11.65M 10-Q · filed 2024-12-13 | |
| 2024-07-31 | $17.15M 10-Q · filed 2024-09-17 | |
| 2024-04-30 | $20.39M 10-K · filed 2025-08-11 | |
| 2024-01-31 | $22.47M 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $20.81M 10-Q · filed 2023-12-15 | |
| 2023-07-31 | $20.40M 10-Q · filed 2023-09-18 | |
| 2023-04-30 | $586.58K 10-K · filed 2024-08-13 | |
| 2023-01-31 | $827.83K 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $1.31M 10-Q · filed 2022-12-14 | |
| 2022-07-31 | $1.09M 10-Q · filed 2022-09-14 | |
| 2022-04-30 | $704.37K 10-K · filed 2023-07-31 | |
| 2022-01-31 | $612.98K 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $186.12K 10-Q · filed 2021-12-14 | |
| 2021-07-31 | $924.97K 10-Q · filed 2021-09-14 | |
| 2021-04-30 | $724.78K 10-K · filed 2022-07-28 | |
| 2021-01-31 | $648.70K 10-Q · filed 2021-03-12 | |
| 2020-10-31 | $664.74K 10-Q · filed 2020-12-11 | |
| 2020-07-31 | $1.19M 10-Q · filed 2020-09-11 | |
| 2020-04-30 | $1.08M 10-K · filed 2021-08-10 | |
| 2020-01-31 | $1.02M 10-Q · filed 2020-03-13 | |
| 2019-10-31 | $803.86K 10-Q · filed 2019-12-23 | |
| 2019-07-31 | $606.56K 10-Q · filed 2019-09-13 | |
| 2019-04-30 | $742.85K 10-K · filed 2020-08-13 | |
| 2019-01-31 | $471.24K 10-Q · filed 2019-03-14 | |
| 2018-10-31 | $662.37K 10-Q · filed 2018-12-14 | |
| 2018-07-31 | $882.94K 10-Q · filed 2018-09-12 | |
| 2018-04-30 | $644.17K 10-K · filed 2019-08-13 | |
| 2018-01-31 | $887.16K 10-Q · filed 2018-03-19 | |
| 2017-10-31 | $566.96K 10-Q · filed 2017-12-14 | |
| 2017-07-31 | $865.68K 10-Q · filed 2017-09-13 | |
| 2017-04-30 | $580.25K 10-K · filed 2018-07-20 | |
| 2017-01-31 | $578.27K 10-Q · filed 2017-03-13 | |
| 2016-10-31 | $448.99K 10-Q · filed 2016-12-02 | |
| 2016-07-31 | $456.46K 10-Q · filed 2016-09-06 | |
| 2016-04-30 | $637.64K 10-K · filed 2017-07-27 | |
| 2016-01-31 | $1.07M 10-Q · filed 2016-03-08 | |
| 2015-10-31 | $1.08M 10-Q/A · filed 2016-01-19 | |
| 2015-07-31 | $1.16M 10-Q/A · filed 2016-01-19 | $1.19M 10-Q · filed 2015-08-25 |
| 2015-04-30 | $1.52M 10-K · filed 2016-07-29 | $2.01M 10-K · filed 2015-07-29 |
| 2015-01-31 | $378.51K 10-Q · filed 2015-03-13 | |
| 2014-10-31 | $276.86K 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $371.39K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $373.67K 10-K/A · filed 2016-01-19 | |
| 2014-01-31 | $479.28K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $990.97K 10-Q · filed 2013-12-16 | |
| 2013-07-31 | $994.15K 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $3.80M 10-K · filed 2014-08-04 | |
| 2013-01-31 | $3.90M 10-Q · filed 2013-03-26 | |
| 2012-10-31 | $3.79M 10-Q · filed 2012-12-26 | |
| 2012-07-31 | $4.03M 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $3.79M 10-K · filed 2013-07-29 | |
| 2012-01-31 | $3.53M 10-Q · filed 2012-03-21 | |
| 2011-10-31 | $3.52M 10-Q · filed 2011-12-15 | |
| 2011-07-31 | $3.40M 10-Q/A · filed 2011-09-20 | |
| 2011-04-30 | $3.39M 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |